Cocrystal Pharma and Bristol-Myers Squibb are competing for investment as healthcare companies.
1 report, 1 independent
Updated Sun 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cocrystal Pharma and Bristol-Myers Squibb are competing for investment as healthcare companies.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cocrystal Pharma
company in Bothell, United States
Nothing else this week.
-
Bristol-Myers Squibb
American pharmaceutical company
Related events
- Bristol-Myers Squibb and Pfizer are co-marketing Eliquis, while both companies are noted as dividend payers.
- Bristol-Myers Squibb has taken ownership of Celgene's drug.
- Market competition observed in the large-cap healthcare sector involving Bristol-Myers Squibb and Orion OYJ.
- Bristol-Myers Squibb and Johnson & Johnson are both companies that are currently targets of LB Pharmaceuticals.
- Manufacturers Life Insurance Company reduced its share position in Bristol-Myers Squibb.